P1 | P2 | P3 | P4a | P4b | P5 | P6 | P7a | P7b | P7c | P8 | P9 | P10 | P11 | P12 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sex | M | M | F | M | M | M | F | F | F | M | M | M | F | F | F |
Age at diagnosis | 9 m | 27 y | 14 y | 4 y | 6 m | 9 y | 5 m | 15 m | 14 m | 13 m | 19 m | 16 y | 16 y | 18 m | 8 m |
Ethnicity | Mazedonia | Serbia | Iran | Turkey | Turkey | Turkey | Netherland | Somalia | Somalia | Somalia | Turkey | Turkey | Spain | Turkey | Iraqui |
Consanguinity | + | - | + | + | + | + | - | + | + | + | + | + | + | + | + |
Urinary LP/HP # | 8.16 | 5.47 | 5.59 | 4.02 | 9.5 | 5.15 | 8.48 | 8.32 | 9.03 | not done | 6.98 | 6.1 | 6.51 | 6.6 | 7.8 |
PLOD1 mutation | Dup/Dup | p.L85P/p.L85P * | c.1471-1 G > A/ c.1471-1 G > A* | Dup/Dup | Dup/Dup | c.1095C > T/ c.1095C > T* | c.1651-2 A > G/ c.1651-2 A > G* | p.G678R/p.G678R | p.G678R/ p.G678R | p.G678R/ p.G678R | DNA not available | p.Q345X/ p.Q345X* | c.466+ 1G > A/ c.466+ 1G > A* | DNA not available | p.Trp419leufsX48*/ p.Trp419leufsX48* |
muscular hypotonia at birth | + | - | + | + | + | + | + | + | + | + | + | + | + | + | + |
Kyphoscoliosis at birth | + | - | + | + | + | + | + | + | - | - | + | + | - | + | + |
Marfanoid habitus | + | + | + | + | + | + | + | + | + | - | - | + | - | - | + |
Delayed gross motor development | + | - | + | + | + | + | + | + | + | + | + | + | + | + | + |
delayed cognitive development | - | - | - | - | - | - | - | - | - | - | + | + | + | + | + |
Rupture of artery | - | + | - | - | - | - | - | - | - | - | - | - | - | - | + |
Smooth velvety skin | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + |
Extensibel fragile skin | - | - | + | ? | ? | + | + | ? | + | + | + | ? | + | ? | + |
Joint laxity | + | + | + | + | + | + | ? | + | + | + | + | + | + | + | + |
Hip dislocation at birth | + | - | + | - | - | + | - | - | - | - | + | - | - | - | + |
Neuromuscular workup | + | - | - | - | - | + | - | + | - | - | + | - | + | + | - |
Independent walking at age | 2 y | 1.5 y | 4 y | ? | ? | ? | 2 y | n.a. | ° | 2 y | n.a | n.a | 2 y | ° | ° |
*newly described mutation |